Clinical Trial

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Study acronym: GRACE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-10-08; most recent amendment 2026-04-24.
Status change: Not Yet Recruiting → Recruiting 2026-01-08
Trial Details
NCT Number NCT07216742
Lead Sponsor Granata Bio Corporation
Conditions Infertility (IVF Patients)
Enrollment 659 participants
Start Date 2025-11-01
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-27